Following the launch of the Investor Year of Action on Antimicrobial Resistance (AMR) at Davos, the PRI’s CEO Fiona Reynolds, sat down with Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance.

Together they discuss what AMR is, why it should be on everyone’s radar and critically, the role investors can play in making change happen.

This episode was recorded prior to the coronavirus outbreak in Europe. While a separate matter to AMR, Covid-19 is another issue we must act now on.